MedPath
Found 9023 clinical trials|View Analysis
Sort by:

Safety and Immunogenicity Evaluation of the Recombinant Flagellin Protein Adjuvant

Early Phase 1
Not yet recruiting
Conditions
COVID - 19
Interventions
Biological: KFD1(0µg )
Biological: KFD1(20µg)
Biological: KFD1(40µg)
Biological: KFD1(80µg)
First Posted Date
2025-01-10
Last Posted Date
2025-01-10
Lead Sponsor
Shanghai Public Health Clinical Center
Target Recruit Count
60
Registration Number
NCT06768697
Locations
🇨🇳

Shanghai Public Health Clinical Center,Fudan University, Shanghai, Jinshan District, China

Study to Evaluate the Efficacy and Safety of Plitidepsin in Adults with Post-COVID-19 Condition (PCC)

Phase 2
Not yet recruiting
Conditions
Post COVID-19 Condition
Long COVID Syndrome
Persistent COVID-19
Persistent COVID Condition
Long COVID
Interventions
Drug: Plitidepsin 1.5 mg/day
Drug: Placebo and Plitidepsin 1.5mg/day
Drug: Placebo
First Posted Date
2025-01-09
Last Posted Date
2025-01-09
Lead Sponsor
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia
Target Recruit Count
90
Registration Number
NCT06766825
Locations
🇪🇸

Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain

Transcranial Non-invasive Electrical Stimulation of the Vagus Nerve in Hospitalized Moderate-to-severe COVID-19 Patients

Not Applicable
Completed
Conditions
COVID-19
First Posted Date
2025-01-09
Last Posted Date
2025-01-09
Lead Sponsor
University of Medicine and Pharmacy "Victor Babes" Timisoara
Target Recruit Count
83
Registration Number
NCT06767241
Locations
🇷🇴

Infectious Diseases and Pulmonology Clinical Hospital Timisoara, Timisoara, Timis, Romania

Prone Duration in COVID-19 ARDS

Completed
Conditions
COVID - 19
Acute Respiratory Distress Syndrome (ARDS)
First Posted Date
2025-01-09
Last Posted Date
2025-01-09
Lead Sponsor
Istanbul University - Cerrahpasa
Target Recruit Count
79
Registration Number
NCT06765759
Locations
🇹🇷

İstanbul University - Cerrahpaşa, Cerrahpaşa Medical Faculty, Istanbul, Turkey

Evaluation of Innovative School-based Interventions on Health Outcomes Among Primary School Students During Post COVID-19 Pandemic

Not Applicable
Not yet recruiting
Conditions
Childhood Obesity
Sleep Problems
Physical Activity
First Posted Date
2025-01-09
Last Posted Date
2025-01-09
Lead Sponsor
Chinese University of Hong Kong
Target Recruit Count
408
Registration Number
NCT06766890
Locations
🇭🇰

The Chinese University of Hong Kong, Hong Kong, Hong Kong

Optimising General Practice Long COVID Care - an Educational Intervention.

Not Applicable
Not yet recruiting
Conditions
Long COVID
First Posted Date
2025-01-09
Last Posted Date
2025-01-09
Lead Sponsor
University College Dublin
Target Recruit Count
72
Registration Number
NCT06765421

Investigating the Efficacy of OMT to Recover Olfactory Perception After COVID-19

Not Applicable
Recruiting
Conditions
Anosmia
First Posted Date
2025-01-09
Last Posted Date
2025-01-09
Lead Sponsor
Burrell College of Osteopathic Medicine
Target Recruit Count
32
Registration Number
NCT06766279
Locations
🇺🇸

Burrell College of Osteopathic Medicine, Las Cruces, New Mexico, United States

Evaluation of Immunogenicity of COVID-19 Vaccine in Chinese Population

Completed
Conditions
COVID
First Posted Date
2025-01-08
Last Posted Date
2025-01-08
Lead Sponsor
Xijing Hospital
Target Recruit Count
100
Registration Number
NCT06763887
Locations
🇨🇳

The First Affiliated Hospital of Air Force Military Medical University, Xi'an City, Shaanxi, China

Retail COVID-19 Study

Recruiting
Conditions
COVID - 19
Interventions
Biological: FDA approved mRNA vaccines
First Posted Date
2025-01-07
Last Posted Date
2025-01-08
Lead Sponsor
Biomedical Advanced Research and Development Authority
Target Recruit Count
3600
Registration Number
NCT06761612
Locations
🇺🇸

Walgreens - 3298 S John Young Pkwy, Kissimmee, Florida, United States

🇺🇸

Walgreens - 1554 E 55th St, Chicago, Illinois, United States

🇺🇸

Walgreens - 4385 S Archer Ave, Chicago, Illinois, United States

and more 17 locations

RDW, Platelet Kinetics and Survival Outcome in Covid-19 Hospitalized Patients.

Active, not recruiting
Conditions
Infection by SARS-COV-2
First Posted Date
2025-01-01
Last Posted Date
2025-01-01
Lead Sponsor
Sismanoglio General Hospital
Target Recruit Count
500
Registration Number
NCT06755658
Locations
🇬🇷

Sismanoglio - Amalia Fleming General Hospital/ A.Fleming Clinical Unit, Athens, Attica, Greece

© Copyright 2025. All Rights Reserved by MedPath